Image

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

Not Recruiting
12-19 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine if nVNS will decrease autonomic symptom intensity (COMPASS-31 and Child Functional Disability Inventory) in adolescent patients with postural orthostatic tachycardia syndrome (POTS) in comparison to standard recovery STEPS management.

Description

Project purpose: The investigators will study the use of non invasive vagal nerve stimulation in newly diagnosed adolescent patients with POTS to see if symptom management improves over 2 months. Surveys will include COMPASS-31. Child Functional Disability Inventory, and PHQ-9. Patient logs will evaluate headache frequency, exercise duration and VNS use.

Research objectives: The investigators hypothesize that:

Primary Aim 1. Use of noninvasive vagal nerve stimulation will decrease autonomic symptom intensity compared to control group.

Primary Aim 2. Use of noninvasive vagal nerve stimulator will improve child function.

Primary Aim 3. Heart rate elevation measured by head up tilt table test will decrease in the treatment group compared to the control group.

Secondary goals include:

Secondary Aim 1: To determine if utilization of noninvasive vagal nerve stimulation influences headache frequency Secondary Aim 2: Determine if utilization of noninvasive vagal nerve stimulation will influence weekly duration of aerobic exercise.

Secondary Aim 3: Determine if utilization of noninvasive vagal nerve stimulator results in significant side effects, particularly depression, in adolescent patients.

Eligibility

Inclusion criteria:

  1. Patient's age 12-19 years of age
  2. Newly diagnosed POTS at Mayo Clinic in Rochester
  3. Head up tilt table test results in a heart rate increase of 40 or more bpm
  4. Consent is able to be obtained appropriately per age

Exclusion criteria:

  1. POTS patients with orthostatic hypotension
  2. POTS patients with vasovagal syncope
  3. Use of medications other than midodrine or metoprolol
  4. Inability to independently utilize the GammaCore device
  5. Inability to independently complete surveys or patient logs
  6. Patients receiving hormonal therapy other than birth control
  7. Pregnancy
  8. Prior neck surgery
  9. Metallic implant present
  10. Cardiac disorder
  11. Presence of an eating disorder
  12. Use of a feeding tube

Study details
    Postural Tachycardia Syndrome
    Autonomic Dysfunction
    Postural Orthostatic Tachycardia Syndrome
    POTS - Postural Orthostatic Tachycardia Syndrome

NCT06268288

Mayo Clinic

28 November 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.